The Harvey–Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study

Echarri, Ana; Vera, Isabel; Ollero, Virginia; Aràjol, C; Riestra, Sabino; Robledo, Pilar; Calvo, Marta; Gallego, F.; Ceballos, Daniel; Castro, Beatriz; Aguas, Mariam; García-López, Santiago; Marín-Jiménez, Ignacio; Chaparro, María; Mesonero, Paco; Guerra, Iván; Guardiola, Jordi; Nos, Pilar; Muñiz, Javier

doi:10.1089/tmj.2018.0264

Cited by 22 publications

(16 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, clinicians tended to track the change in HBI/SCCAI, rather than the absolute score, to understand their severity. Echarri et al 12 compare patient-reported HBI on smartphones to clinician-reported HBI and confirmed a sensitivity of 92% and specificity of 94%. Clinician and participant feedback showed that participants tended to score themselves higher than clinicians on self-examination and extraintestinal manifestations.…”

Section: Discussionmentioning

confidence: 91%

Remote clinical assessment of inflammatory bowel disease using smartphone applications

Mitchell¹,

Walmsley²

2021

NZMSJ

View full text Add to dashboard Cite

INTRODUCTIONInflammatory bowel disease (IBD) is a chronic, relapsing disease requiring ongoing monitoring. Smartphone applications will allow remote monitoring of a large geographical catchment of Waitematā District Health Board (WDHB). IBDSmart (Otago University/Gut Health Network) is a phone application for patients to self-report flares and monitor disease using validated scoring systems. IBDSmart has been shown to be non-inferior to standard care and to reduce face-to-face appointments. IBD-Disk ® provides validated visual representation of Quality of Life (QoL), allowing for patient-centred discussions in clinic and tracking QoL with treatment. The aim of this study was to understand if these applications are feasible in the outpatient setting in terms of patient/clinician feedback and validity of patient's scores. METHODSIBD patients attending WDHB gastroenterology clinics were recruited over the phone, emailed brochures, and asked to complete IBDSmart/IBD-Disk ® surveys one to two weeks before their appointments. Clinicians were provided with Harvey Bradshaw Index (HBI)/ Simple Clinical Colitis Activity Index (SCCAI) at appointment and reminded to discuss IBD-Disk ® responses. Feedback was collected using five-point scoring of five affirmative statements. RESULTSEighty-four participants were contacted; 45 used IBDSmart and 10 used IBD-Disk ® . Nine clinicians were involved. There were technical issues; IBDSmart links expired within 48hours, and IBD-Disk ® does not work in Android Operating Systems 9.0-11.0. The majority (≥60%) of participants and clinicians either completely agreed or agreed with statements. Correlation between clinician and patient scores was moderate (R 2 for HBI 0.52, for SCCAI 0.49). CONCLUSIONSBoth applications are highly useable and accepted by patients and clinicians. However, technological issues need to be addressed. Correlation of scores could be improved through increased patient education and application design.

show abstract

Section: Discussionmentioning

confidence: 91%

Remote clinical assessment of inflammatory bowel disease using smartphone applications

Mitchell¹,

Walmsley²

2021

NZMSJ

View full text Add to dashboard Cite

show abstract

“…Comprehensiveness was also rated insufficient in 18 other instruments; however, the reviewers’ rating was decisive in all of those cases, as no content validity studies or clear development studies on comprehensiveness were identified. Only the HBImApp 55 had a doubtful quality content validity study on comprehensiveness, though the criteria for comprehensiveness were rated as indeterminate. The EIBDQ 76 was the only instrument rated insufficient for all three aspects.…”

Section: Resultsmentioning

confidence: 99%

Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

Andel

Koopmann

Crouwel

et al. 2020

Journal of Crohn's and Colitis

View full text Add to dashboard Cite

Background and Aims Patient-reported outcome measures are increasingly important in daily care and research in inflammatory bowel disease [IBD]. This study provides an overview of the content and content validity of IBD-specific patient-reported outcome measures on three selected constructs. Methods Databases were searched up to May 2019 for development and/or content validity studies on IBD-specific self-report measures on health-related quality of life, disability, and self-report disease activity in adults. Evidence was synthesised on content validity in three aspects: relevance, comprehensiveness, and comprehensibility following the COnsensus-based Standards for the selection of health Measurement INstruments methodology. Questionnaire items were organised in themes to provide an overview of important aspects of these constructs. Results For 14/44 instruments, 25 content validity studies were identified and 25/44 measures had sufficient content validity, the strongest evidence being of moderate quality, though most evidence is of low or very low quality. The Crohn’s Life Impact Questionnaire and IBD questionnaire-32 on quality of life, the IBD-Control on disease activity, and the IBD Disability Index Self-Report and its 8-item version on disability, have the strongest evidence of sufficient relevance, comprehensiveness, and comprehensibility, ranging from moderate to very low quality. A fair number of recurring items themes, possibly important for the selected constructs, was identified. Conclusions The body of evidence for content validity of IBD-specific health-related quality of life, self-report disease activity, and disability self-report measures is limited. More content validity studies should be performed after reaching consensus on the constructs of interest for IBD, and studies should involve patients.

show abstract

“…In particular, for long-term gastrointestinal disorders, such as IBD, which are characterized by an unstable disease course with recurrent remission and exacerbation, mHealth apps could be a promising approach for symptom monitoring with an early detection of disease relapse. As previous studies have shown that self-reporting symptom diaries correlate with disease activity index for Crohn disease [ 70 , 71 ], validated symptom assessment questionnaires could be implemented in future mHealth apps.…”

Section: Discussionmentioning

confidence: 99%

Mobile Apps for the Management of Gastrointestinal Diseases: Systematic Search and Evaluation Within App Stores

Messner¹,

Sturm²,

Terhorst³

et al. 2022

J Med Internet Res

View full text Add to dashboard Cite

Background Gastrointestinal diseases are associated with substantial cost in health care. In times of the COVID-19 pandemic and further digitalization of gastrointestinal tract health care, mobile health apps could complement routine health care. Many gastrointestinal health care apps are already available in the app stores, but the quality, data protection, and reliability often remain unclear. Objective This systematic review aimed to evaluate the quality characteristics as well as the privacy and security measures of mobile health apps for the management of gastrointestinal diseases. Methods A web crawler systematically searched for mobile health apps with a focus on gastrointestinal diseases. The identified mobile health apps were evaluated using the Mobile Application Rating Scale (MARS). Furthermore, app characteristics, data protection, and security measures were collected. Classic user star rating was correlated with overall mobile health app quality. Results The overall quality of the mobile health apps (N=109) was moderate (mean 2.90, SD 0.52; on a scale ranging from 1 to 5). The quality of the subscales ranged from low (mean 1.89, SD 0.66) to good (mean 4.08, SD 0.57). The security of data transfer was ensured only by 11 (10.1%) mobile health apps. None of the mobile health apps had an evidence base. The user star rating did not correlate with the MARS overall score or with the individual subdimensions of the MARS (all P>.05). Conclusions Mobile health apps might have a positive impact on diagnosis, therapy, and patient guidance in gastroenterology in the future. We conclude that, to date, data security and proof of efficacy are not yet given in currently available mobile health apps.

show abstract

The Harvey–Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn Study

Cited by 22 publications

References 28 publications

Remote clinical assessment of inflammatory bowel disease using smartphone applications

Remote clinical assessment of inflammatory bowel disease using smartphone applications

Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

Mobile Apps for the Management of Gastrointestinal Diseases: Systematic Search and Evaluation Within App Stores

Contact Info

Product

Resources

About